Literature DB >> 1855774

Percutaneous transhepatic biliary drainage--twelve years' experience.

G M Gazzaniga1, A Faggioni, G Bondanza, C Bagarolo, M Filauro.   

Abstract

Our experience with percutaneous transhepatic biliary drainage in a total of 362 patients carried out between January 1977 and December 1988 is described. Three hundred and fifty drains were correctly placed, and results were good in 285 (81.5%), fair in 53 (15.1%) and poor in 12 (3.4%). In 12 of the total number of cases (3.4%) it was not possible to position the drain effectively. The mortality rate of the method was 0.8% (3 cases). Complications were as follows: obstruction 7 (1.9%), dislodgement 15 (4.1%), hemobilia 15 (4.1%), hemoperitoneum 1 (0.2%), cholangitis 6 (1.6%), and choleperitoneum 10 (2.7%). In view of the good results and low incidence of complications the conclusion is that in skilled hands, percutaneous transhepatic biliary drainage is a very useful method that should be available in any center specializing in hepatobiliary surgery.

Entities:  

Mesh:

Year:  1991        PMID: 1855774

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

1.  Acute pancreatitis: an under-recognized risk of percutaneous transhepatic distal biliary intervention.

Authors:  A Z Al-Bahrani; A Holt; A M Hamade; G H Abid; H-U Laasch; S J O'Shea; S H Lee; B J Ammori
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

2.  Interventional therapy for the treatment of severe hemobilia after percutaneous transhepatic cholangial drainage: a case series.

Authors:  Huicun Cao; Jian Liu; Tianxiao Li; Guangshao Cao; Gangqin Xu; Shuiting Zhai; Jiangyu Xue; Ziliang Wang; Shuaitao Shi; Weixing Bai
Journal:  Int Surg       Date:  2013 Jul-Sep

3.  Percutaneous transhepatic biliary stent placement in the palliative management of malignant obstructive jaundice: initial experience in a tertiary center in Ghana.

Authors:  Benjamin Dabo Sarkodie; Benard Ohene Botwe; Edmund Kwadwo Kwakye Brakohiapa
Journal:  Pan Afr Med J       Date:  2020-09-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.